Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha-Glucosidase inhibitors

H E Lebovitz1

  • 1Department of Endocrinology, Metabolism, and Diabetes, State University of New York, Health Science Center at Brooklyn, New York, USA.

Endocrinology and Metabolism Clinics of North America
|October 6, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.

Diabetes, obesity & metabolism·2015
Same author

Treatment of Patients with Obese Type 2 Diabetes with Tantalus-DIAMOND® Gastric Electrical Stimulation: Normal Triglycerides Predict Durable Effects for at Least 3 Years.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2015
Same author

Fasting plasma triglycerides predict the glycaemic response to treatment of type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm.

Diabetic medicine : a journal of the British Diabetic Association·2013
Same author

New treatments of diabetes: the beta-amylin agonists.

Annales d'endocrinologie·2008
Same author

Diagnosis, classification, and pathogenesis of diabetes mellitus.

The Journal of clinical psychiatry·2002
Same author

Oral therapies for diabetic hyperglycemia.

Endocrinology and metabolism clinics of North America·2001
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Alpha-glucosidase inhibitors lower blood glucose by slowing carbohydrate digestion and absorption. These antihyperglycemic agents effectively reduce postprandial glucose and HbA1c levels in patients with type 2 diabetes.

Area of Science:

  • Pharmacology
  • Endocrinology
  • Gastroenterology

Background:

  • Alpha-glucosidase inhibitors are antihyperglycemic agents.
  • They function by delaying carbohydrate digestion and absorption.
  • Their mechanism involves inhibiting brush border enzymes in enterocytes.

Purpose of the Study:

  • To summarize the mechanism of action and efficacy of alpha-glucosidase inhibitors.
  • To highlight their role in managing hyperglycemia.

Main Methods:

  • Competitive inhibition of alpha-glucosidase enzymes.
  • Delaying the breakdown of complex carbohydrates into monosaccharides.

Main Results:

  • Reduced postprandial plasma glucose levels by 40-50 mg/dL in non-insulin-dependent diabetes mellitus (NIDDM) patients.

Related Experiment Videos

  • Decreased hemoglobin A1c (HbA1c) by 0.5% to 1.0% in NIDDM patients.
  • Primary action is to mitigate postprandial hyperglycemia.

    • Conclusions:

    • Alpha-glucosidase inhibitors are effective antihyperglycemic agents.
    • They play a significant role in managing blood glucose control in diabetes mellitus.
    • Their efficacy is demonstrated by reductions in both postprandial glucose and HbA1c levels.